• Shark Cartilage Powder
• Enhanced Shark Cartilage
• Purified Chondroitin Sulphate
• Glucosamine
• Squalene
• Creatine
• MCHC
• Propolis Powder

Creatine

Creatine Molecule

Creatine is a nitrogen-containing organic acid that occurs naturally in the tissues of vertebrates, primarily skeletal muscle and brain, and helps to supply energy by increasing the formation of Adenosine Triphosphate (ATP). In these tissues it serves a critical role in replenishing ATP (via the phosphocreatine/ATP system) during periods of high energy demand. Supplemental creatine has the ability to increase muscle content of phosphocreatine, thus allowing the muscle to rapidly regenerate ATP as a source of energy during times, for example, of exercise load ¹

Physiological and sports exercise research over the past 10-15 years has shown that oral creatine supplementation (5 – 20 g/day) would appear to be safe and largely free of adverse side-effects, while at the same time showing practical improvements in the overall physiological response to resistance exercise. These improvements included enhancement in the maximal force production of muscles for both men and women².

It has also been reported that creatine supplementation may improve cognitive performance and memory³

Creatine monohydrate, creatine hydrochloride and creatine ethyl ester from New Vision Biotech are available as free-flowing white powders in 5, 10 and 20 kg bags. Bulk quantity (>200 kg/order) discounts apply.

1. Spillane, M., Schoch, R., Cooke, M. et al. (February 2009). “The effects of creatine ethyl ester supplementation combined with heavy resistance training on body composition, muscle performance, and serum and muscle creatine levels”. J. Int. Soc. Sports Nutr. 6: 6.
2. Bemben MG, Lamont HS (2005). “Creatine supplementation and exercise performance: Recent findings”. Sports Medicine 35: 107–125.
3. Rae C, Digney AL, McEwan SR, Bates TC (October 2003). “Oral creatine monohydrate supplementation improves brain performance: A double-blind, placebo-controlled, cross-over trial”. Pro. Biolog. Sci. / The Royal Society 270: 2147–2150.